Would you trust a robot with your life?

Autonomous surgery isn’t science fiction anymore. It’s already happened.

Would you trust a machine to operate on you?

To cut, stitch, and repair the most fragile tissue in your body without a human hand guiding it?

That question isn’t hypothetical anymore.

Autonomous surgery has already happened, and the pace of progress is accelerating faster than most people realize.

At Johns Hopkins, a team developed a robot that performed bowel anastomoses on pigs. That's one of the most delicate abdominal procedures a doctor can perform.

All eight were successful, with precision and without fatigue, hesitation, or trembling hands.

A machine watched, learned, and then executed one of the hardest procedures in surgery.

The researchers who built it described the achievement as a milestone on the path toward clinical deployment, and in their lab notes they pointed out how the robot made adjustments mid-procedure based on subtle visual cues a human might miss.

And this is just the start.

AI is now closing sutures, recognizing tissue, and dissecting with increasing autonomy.

Systems are being trained on thousands of hours of surgical video, learning from the collective experience of surgeons around the world.

Each iteration moves the robot from assistant to co-pilot to, eventually, primary operator.

The robot’s role in the OR grows larger with each passing year, and with it comes the question of what medicine looks like when the most precise pair of hands isn’t even human.

What’s At Stake

Surgeons save lives every day.

They do extraordinary work under immense pressure. But they’re human, get tired, and can sometimes make fatal mistakes.

On top of all that, they can only be in one operating room at a time.

And by 2036, the U.S. could be short as many as 19,900 surgeons. Globally, the gap is even more staggering, with billions lacking access to safe surgical care.

Autonomy gives us a way to scale the skill of the very best.

Imagine a world where the average outcome matches the best outcome… where the care you receive in a rural hospital is indistinguishable from the care at a world-class medical center… Where the baseline level of surgical safety rises for everyone.

Autonomy promises fairness. It promises that the accident of your address no longer determines your odds of survival.

Think about what that means for families. The mother in a rural town. The child in an underserved city. The patient in a country with few surgeons.

Each of them deserves the same shot at life as someone in a wealthy urban hospital. Autonomy is the only realistic way to close that gap at scale.

Who’s Building This Future

Several companies are racing to define what autonomous surgery will look like:

Intuitive Surgical — weaving AI into its da Vinci systems to keep its lead and move closer to autonomy. Its latest da Vinci 5 system includes upgrades in sensing and analytics designed to prepare for more automation.

Johnson & Johnson — pouring billions into its Ottava platform to break into general surgery, with trials scheduled to begin soon. Backed by one of the largest R&D budgets in healthcare, J&J has the resources to push autonomy into mainstream adoption.

Zimmer Biomet — expanding its ROSA platform in neurosurgery and orthopedics, integrating imaging and robotics to guide delicate procedures with millimeter accuracy.

Moon Surgical — building lower-cost systems so smaller hospitals can join the future too, aiming to democratize access to robotics rather than keeping it in elite centers.

And remember, these aren’t mere experiments.

These are working platforms in operating rooms today, each step adding more automation, more intelligence, and more independence from the surgeon’s hand.

The race we’re witnessing is about who gets there first and how it will be integrated into care.

The Trust Question

Will people trust a machine with their life? Even if the numbers show outcomes are better? That’s the hurdle.

Families want a steady human voice saying, “I’ll take care of you.”

They want to believe someone is accountable, someone who can look them in the eye. Autonomy won’t erase that need for reassurance.

But the alternative is a system still ruled by human error, geography, and shortage.

I’ve lived that reality. I’ve heard the words, “She’s not going to make it.”

If autonomy can spare even one family from hearing those words, then it might be a future worth building.

The reality is that the technology is no longer a question of if. It exists, it works, and it will only get better.

What remains uncertain is trust.

Will patients accept it? Will regulators move fast enough? Will insurers pay for it? Will surgeons embrace it as an ally rather than resist it as a threat? These are unanswered human questions, because the tech is already there and improving every day.

Whether people decide to put their lives in the hands of machines remains to be seen.

But the trajectory is clear. Autonomous surgery is here, and it is advancing. The question is whether we’ll be ready to trust it and how long it will take before choosing a machine feels as natural as choosing a surgeon.

What about you? Would you trust it? Answer below and I’ll publish the results of the poll.

Have a great weekend and I’ll see you on Monday,

Double D

Poll: Would you trust a machine, without a human doctor operator, to operate on you?

Login or Subscribe to participate in polls.

🔓 Premium Content Begins Here 🔒

In today’s Premium Section, I have a new recommendation I’m buying during a federally mandated infrastructure buildout in rare earths.

I hope you’ve been paying attention because many of our picks are currently beating the S&P by up to 4-to-1 this year.

Most financial newsletters charge $500, $1,000, even $5,000 per year. Why? Because they know they can.

I don’t.

I built my wealth the old-fashioned way, not by selling subscriptions.

That’s why I priced this at $25/month, or $250/year.

Not because it’s low quality, but because I don’t need to charge the typical prices other newsletters charge.

One good trade, idea, or concept could pay for your next decade of subscriptions.

The question isn’t ‘Why is this so cheap?’ The question is, ‘Why would I charge more?’

P.S. If this newsletter were $1,000 per year, you’d have to think about it.

You’d weigh your options. You’d analyze the risk.

But it’s $25 a month.

That’s the price of a bad lunch decision.

And remember, just one good idea could pay for your subscription for a decade.